Akash Goel

Anesthesiologist & Pain Medicine Physician @ University of Toronto • Clinician & Investigator • Neuromodulation • Facial Pain • Psychedelics & Psychotherapy

[Dr. Mark Bonta, MD, FRCPC @DocBonta]

🤔 Chronic pain is multifaceted, varying widely among patients. @akashgoelmd explores how #Neuroplasticity, #CBT & advanced tools like #fMRI shed light on this puzzle. Is multidisciplinary care the key to progress? Tune in: https://t.co/9epzIdTdis
#PainScience #FutureOfMedicine

[Akash Goel @AkashGoelMD]

An update on the latest Canadian guidelines for the management of opioid use disorders as covered by Medscape - overall, buprenorphine and methadone have been brought to a level playing field. See my comments in this Medscape article!

[Erik Greb @MedscapeErik]

The updated Canadian guideline on managing opioid use disorder recommends buprenorphine and methadone as first-line treatments. The update reflects the latest evidence of these medicines' efficacy. #opioids @drpselby @doc_sud @AkashGoelMD https://t.co/xKyY6ztiZr

[Temerty Medicine @uoftmedicine]

#TemertyMed/@UnityHealthTO Dr. Akash Goel is launching a global trial to test the impact of MDMA on chronic nerve pain. https://t.co/dcVUzXtV8n

[Akash Goel @AkashGoelMD]

https://t.co/aj5B2jtK9X

The placebo response is a key factor in the effectiveness of our treatments. For those who suffer, relief is paramount, regardless of the 'why.' But by studying the power of placebo, we can harness it fully to enhance healing. Let's unlock its potential.

[Department of Anesthesiology & Pain Medicine @UofTanesthesia]

Congratulations to Dr. David Mazer who has received the prestigious Cara Phelan Chair in Critical Care Medicine!

Read more: https://t.co/yv0BpCIynZ

[Harsha Shanthanna @harshamd5]

SCS: Burst vs. Placebo. It is disappointing that important questions do not get addressed by the authors https://t.co/AVPPepQY3O @NarouzeMD @jonhagedornmd @ASRA_Society @CanadianPain @DProvenzanoMD @IntlNeuromod @AkashGoelMD

[PINNACLE Group @PinnaclePeriop]

The #SMILEstudy has enrolled 20 participants, reaching the half-way mark for our pilot RCT ✅

We are looking forward to completing this study investigating inhaled nitrous oxide as a potential therapeutic for treatment-resistant #depression
@UnityHealthTO

[PINNACLE Group @PinnaclePeriop]

Paper @RAPMOnline led by @calvdiep – @PinnaclePeriop trainee, resident @UofTanesthesia & MSc student @ihpmeuoft – with @drladha @AkashGoelMD @Drhaclarke & Duminda Wijeysundera. It evaluates whether #prescriptionopioid use influences rates of recent self-reported #Cannabis use.

[PINNACLE Group @PinnaclePeriop]

Recent @_Anesthesiology paper led by @naheedjivraj & @wunschcritcare that evaluate trends in postop #analgesia prescriptions in older adults. Multinational team with Andrea Hill, Duminda Wijeysundera, Brian Bateman @drladha @AkashGoelMD & @neumanmd. https://t.co/8xv5LFxjKn

[Anesthesiology Journals @_Anesthesiology]

In a large observational cohort, the use of NSAIDs in the early postoperative period after major gastrointestinal #surgery was not associated with a greater risk of either acute kidney injury or anastomotic leak. Learn more: https://t.co/k68Styxe9k

[Akash Goel @AkashGoelMD]

https://t.co/ALOoQvDxXp

Interesting findings regarding Burst Stimulation. No difference in disability outcomes when compared to placebo stimulation!

[Akash Goel @AkashGoelMD]

@Vafisalmasi @StanfordPain @DrSeanMackey @drmingkao @DrMichaelSLeong @DrOttestad @asterkawi @DrHeatherKing @DrKristenSlater @ScottPritzlaff @RaviPrasadPhD Well done vafi et al!

[Akash Goel @AkashGoelMD]

@TawfikLab @BrighamWomens Congrats!! Well deserved :)

[Emily McDonald @DrEmilyMcD]

Gabapentin Increasingly Implicated in Overdose Deaths

I’ve said it before and I’ll say it again: GABA-WHY?

#TwitterRx
⁦@MedSaferTool⁩

#deprescribing
⁦@DeprescribeNet⁩
⁦@DrToddLee⁩
https://t.co/1kjFCJeCg3

[Akash Goel @AkashGoelMD]

@bagchi_eeshan @AbdelBeheri Martinez to arsenal ..

[Jonathan Reeder @jt_reeder]

Our work on nerve cooling is out in Science! We developed dissolvable devices that cool and numb peripheral nerves as an approach to manage pain without opioids. https://t.co/s9TBHVb7UP

[Neuromodulation Journal @JNeuromod]

A 2020 study showed repetitive transcranial magnetic stimulation in treatment resistant depression patients with comorbid cognitive dysfunction improved verbal memory & depression scores at 3 months post-procedure
https://t.co/9lwJW2ectu @danikapaulomd @Liz_cg_ #TMS #depression

[Akash Goel @AkashGoelMD]

@TawfikLab Fin du monde is dangerous…

[Akash Goel @AkashGoelMD]

@jperez_mcgill @mcgillpainunit Congrats!

[Akash Goel @AkashGoelMD]

@COYSonny7 @FabrizioRomano @Transfers More clean sheets though